Navigation Links
Adeona Announces Second Quarter 2010 Profitability and Achievements
Date:8/16/2010

5 million upon filing of a New Drug Application with the Food and Drug Administration for flupirtine for fibromyalgia and $10 million upon marketing approval.
  • As of today, 97 out of 150 patients have been enrolled in the Trimesta clinical trial studying whether 8 mg of oral Trimesta taken daily over a 2 year period would reduce the rate of relapses in female relapsing-remitting multiple sclerosis patients. The randomized, double-blind, placebo-controlled clinical trial is currently underway at 16 centers in the United States. The clinical trial has received approximately $5.9 million in grant funding to date.

  • As of today, 54 out of 60 subjects have been enrolled in the Zinthionein clinical study testing the therapeutic effects of Adeona's proprietary oral, gastro-retentive, sustained-release zinc and cysteine formulation on cognition in Alzheimer's disease and mild cognitive impairment subjects. The randomized, double-blind, placebo-controlled study is currently underway at 3 centers in the United States. Study subjects are being assessed at 3 and 6 months for serum parameters of zinc and copper as well as changes in cognitive function using standard Alzheimer's disease clinical tests. Adeona expects completion of this clinical study in the first quarter of 2011.

  • HartLab, now renamed Adeona Clinical Laboratory, has added microbiology testing and pediatric testing services. The number of clients at the CLIA-certified diagnostic testing lab has doubled over the past few months. The lab is now open 7 days a week and offers walk-in phlebotomy services. Increased commercialization efforts are starting to result in increases in recurring revenues. Adeona Clinical Laboratory has been obtaining higher rates of reimbursement for the serum-based CopperProof Panel test.


    '/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Adeona Announces HartLab Expansion Into Microbiology Testing Services
2. Adeona Completes Equity Financing and Provides Alzheimers Disease Clinical Study Update
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014 Pharmatech initiated enrollment ... into this game-changing method for matching cancer patients ... clinical trials target specific cancers, disease staging, and ... for the cancer, in the first place. The ... information may not be well known to the ...
(Date:8/28/2014)... Aug. 28, 2014  In anticipation of the upcoming ... made available for the first time. Industry Overview: Medtech ... offers a snapshot of San Diego,s ... everything from the latest employment statistics to current venture capital ... San Diego such a vital part of the ...
(Date:8/28/2014)... Nonin Medical, Inc., the inventor of finger pulse oximetry ... that the Food and Drug Administration (FDA) has cleared ... use in the United States . ... or kiosk through a USB connector and measures oxygen ... The Model 3231 received EU certification last year. ...
Breaking Medicine Technology:Enrollment in Pharmatech's Revolutionary AccessPPM Program Launches 2New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2
... Va., Oct. 6 With October ... Association (NCPA) encourages community pharmacists to demonstrate their ... all aspects of medications, from dispensing to disposal. ... (Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) ...
... 6 Baxano, Inc. ( www.baxano.com ) today announced that ... Technology for Spine Care at the 2010 Spine Technology Awards. ... first place in the Best New Technology in Lumbar Care. ... 2010 Spine Technology Awards Gala in Orlando, FL. Baxano, Inc. ...
Cached Medicine Technology:NCPA Encourages Pharmacists to Promote Medication Expertise from Dispensing to Disposal 2NCPA Encourages Pharmacists to Promote Medication Expertise from Dispensing to Disposal 3Baxano, Inc. Awarded Prestigious 2010 Spine Technology Awards 2
(Date:8/29/2014)... PA (PRWEB) August 29, 2014 "After reading ... who don’t stand very often, I decided that there needed ... periods during the day," said a concerned inventor from Sikestons, ... stand for long periods. It builds endurance and keeps the ... better health. Easy to use and producible in design variations, ...
(Date:8/29/2014)... Only a handful of CPR and basic life ... which are consistent with recent health guidelines, according ... Medicine Australasia , the journal for the Australasian ... recognition and treatment of sudden cardiac arrest are ... of Turkish emergency medicine specialists put together the ...
(Date:8/29/2014)... The Fresh Diet, America’s premier gourmet meal ... Vegetarian meal plan. Originating from The Fresh Diet’s commitment ... is designed to satisfy customers seeking a convenient, worry-free ... Responding to the growing demand by customers for non-meat ... (Forbes) with 14% of Americans identifying vegetarian meals as ...
(Date:8/29/2014)... Dennis Thompson HealthDay Reporter , ... during the early days of the Ebola outbreak in West ... mutates and spreads. Researchers report in the Aug. 28 ... determined the following: The Ebola strains responsible for ... to the very first recorded outbreak of Ebola in central ...
(Date:8/29/2014)... N.C (PRWEB) August 29, 2014 VHA ... awards for excellence in clinical care, honoring nine facilities ... the patient experience. , “At Novant Health, providing quality, ... top priority” said Tom Zweng, MD, executive vice president ... commitment to provide a remarkable experience for each and ...
Breaking Medicine News(10 mins):Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 2Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 3Health News:Gene Research Yields Insights Into Ebola Virus 2Health News:Gene Research Yields Insights Into Ebola Virus 3Health News:Novant Health Recognized for Excellence in Clinical Care 2Health News:Novant Health Recognized for Excellence in Clinical Care 3
... U.S. wildfires are likely to increase in the coming ... the University of Comahue in Argentina and involving the ... outbreaks in the past five centuries with periods of ... ,States like Washington, Oregon, California, Colorado, New Mexico, Arizona ...
... appears that alcohol-induced bone loss resulting from excessive ... or the anti-osteoporosis drug Boniva? (ibandronate), a Loyola ... binge-alcohol drinking reduces bone mass, which is detrimental ... rate of bone loss in osteoporotic post-menopausal women,” ...
... new virus, a modified strain, has led to the death ... Five other pre mature babies are undergoing treatment. ... University Hospital after they were found to be carriers of ... aureus). ,Hospital authorities have confirmed that the baby ...
... Medicine, doctors report on the case of a 35 ... and emergency department //with double vision, slurred speech, drooping ... to be wound botulism. ,Wound botulism is a ... bacterium Clostridium botulinum contaminate a wound, germinate, and produce ...
... promises heavy investment opportunities for Non-Resident Keralites (NRK), making ... long term. ,Kerala Tourism Department has ... 23 – 27 for showcasing the opportunities in the ... a congregation of major hospitals, health insurance companies, policy ...
... approval for consumption of meat and milk from cloned animals ... and John C. Matheson. have declared that it is safe ... offspring. “On no basis can we differentiate the food products ... ,A formal recommendation will be released this week by ...
Cached Medicine News:Health News:New Study Links Western Wildfires to Atlantic Ocean Surface Temperatures 2Health News:New Study Links Western Wildfires to Atlantic Ocean Surface Temperatures 3Health News:Vitamin D or Anti-osteoporosis Drug Reduces Bone Loss from Binge Drinking 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: